Christophe Schilling founded Genomatica in 1998. Since being named CEO in May 2009, he has led Genomatica to widespread recognition as a leader in industrial biotech, with a commercialized first process and plant and multiple leading partners. The company has earned awards for industry impact (recognized in ICIS Top40 Power Players five years in a row), engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest four years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Christophe is Chairman of Biocom, the largest advocate organization for California’s life sciences sector; serves on BIO’s Industrial & Environmental Section Governing Board; serves on the World Economic Forum Global Agenda Council on Biotechnology; and is a member of YPO, an international leadership organization for chief executives. In this exclusive interview with Il Bioeconomista, he talks about the recent agreement with Covestro and the Genomatica’s way towards the bioeconomy.
Interview by Mario Bonaccorso
German materials manufacturer 
Bio-Botanica Inc., a family-owned and operated company, specializing in botanicals for over 45 years and headquartered in Hauppage (New York), has partnered with U.S. biotech company Genomatica to create a new line of botanical extracts using a naturally sourced, sustainably produced butylene glycol. These products, manufactured by Bio- Botanica Inc., feature Genomatica’s proprietary ingredient, Brontide.
Italy-based Aquafil and Californian biotech company Genomatica join forces to create sustainable caprolactam, a key ingredient to producing 100% sustainable nylon. The collaboration between the two companies aims to develop a commercially-advantageous bioprocess (
